Trials / Terminated
TerminatedNCT02722083
Exploratory Study for Allergy Relief Onset
A Single-blind, Randomized, Placebo Controlled, Crossover Pilot Study to Evaluate the Onset of Action of an Antihistamine in Subjects Following Allergen Exposure in an Allergen Chamber
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to explore the onset of effect of an antihistamine in a controlled environment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chlorpheniramine maleate (BAY X002134) | 4 mg tablet, single dose, orally |
| DRUG | Placebo | placebo tablet, single dose, orally |
Timeline
- Start date
- 2016-05-07
- Primary completion
- 2016-05-27
- Completion
- 2016-07-13
- First posted
- 2016-03-29
- Last updated
- 2018-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02722083. Inclusion in this directory is not an endorsement.